posted on 2012-07-11, 00:00authored byWeixue Wang, Ke Wang, Ingrid Span, Johann Jauch, Adelbert Bacher, Michael Groll, Eric Oldfield
The [4Fe–4S] protein IspH in the methylerythritol
phosphate
isoprenoid biosynthesis pathway is an important anti-infective drug
target, but its mechanism of action is still the subject of debate.
Here, by using electron paramagnetic resonance (EPR) spectroscopy
and 2H, 17O, and 57Fe isotopic labeling,
we have characterized and assigned two key reaction intermediates
in IspH catalysis. The results are consistent with the bioorganometallic
mechanism proposed earlier, and the mechanism is proposed to have
similarities to that of ferredoxin, thioredoxin reductase, in that
one electron is transferred to the [4Fe–4S]2+ cluster,
which then performs a formal two-electron reduction of its substrate,
generating an oxidized high potential iron–sulfur protein (HiPIP)-like
intermediate. The two paramagnetic reaction intermediates observed
correspond to the two intermediates proposed in the bioorganometallic
mechanism: the early π-complex in which the substrate’s
3-CH2OH group has rotated away from the reduced iron–sulfur
cluster, and the next, η3-allyl complex formed after
dehydroxylation. No free radical intermediates are observed, and the
two paramagnetic intermediates observed do not fit in a Birch reduction-like
or ferraoxetane mechanism. Additionally, we show by using EPR spectroscopy
and X-ray crystallography that two substrate analogues (4 and 5) follow the same reaction mechanism.